Source: ERJ Open Res, 7 (2) 00528-2020; 10.1183/23120541.00528-2020
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Woo-Jung Song, Ha-Kyeong Won, Suh Young Lee, Han-Ki Park, You Sook Cho, Kian Fan Chung, Liam G. Heaney, Woo Joung Joung. Patients' experiences of asthma exacerbation and management: a qualitative study of severe asthma. ERJ Open Res, 7 (2) 00528-2020; 10.1183/23120541.00528-2020

Member's Comments

No comment yet.

Related content which might interest you: Continuous objective assessment of wheezing in adult asthma patients hospitalised following an acute exacerbation of asthma Source: Eur Respir J 2001; 18: Suppl. 33, 267s Year: 2001 Evolution from mild to severe asthma; the severe asthma clinic perspective Source: International Congress 2019 – Clinical implications of asthma management Year: 2019 Real-life effectiveness of omalizumab in patients with severe persistent allergic asthma: the PERSIST study Source: Annual Congress 2009 - Towards improving asthma control Year: 2009 Baseline symptom scores and future risk of severe exacerbation: The SPARK study Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 Giving voice to patients – experiences during acute exacerbations of COPD Source: Virtual Congress 2021 – Symptoms across respiratory diseases and impact of COVID-19 Year: 2021 The Anglo-French real-life experience of maintenance OCS use in omalizumab-treated patients with severe persistent allergic asthma Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy Year: 2008 Identifying factors associated with severe asthma exacerbations: a retrospective study Source: Eur Respir J 2007; 30: Suppl. 51, 626s Year: 2007 Acute severe asthma: evidence-based management of asthma exacerbations Source: Annual Congress 2008 - PG4 - Paediatric respiratory medicine: wheezing children: asthma and beyond Year: 2008 Biomarkers for the management of severe asthma: a survey Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases Year: 2021 Characteristics of a cohort of patients with work related asthma in a monographic consultation of asthma. Source: International Congress 2019 – Environment, work and respiratory health in occupational and environmental lung diseases Year: 2019 "It‘s like living with a time bomb"– European patients‘ perspective on severe asthma symptoms Source: Annual Congress 2005 - Severe asthma: perception and management Year: 2005 Management of difficult-to-treat severe asthma Source: Eur Respir Mon 2011; 51: 282-296 Year: 2011 Comparison of COPD patients with high and low symptoms from a real-world US survey Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases Year: 2015 Severe outcomes of COVID-19 among patients with COPD and asthma Source: ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020 Year: 2021 Patients’ perception of allergic asthma and their compliance to omalizumab in an Italian clinical setting Source: International Congress 2017 – Asthma management Year: 2017 Characteristics and outcomes of chronic cough in individuals with asthma: a population-based study Source: International Congress 2018 – Asthma and allergy in adults and children and their biomarkers Year: 2018 Prediction of the risk of future exacerbations in patients with severe persistent allergic asthma Source: Annual Congress 2005 - Severe asthma: perception and management Year: 2005 Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Acute exacerbation phenotypes of asthma and COPD: impact on clinical outcomes Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021 Difficult-to-treat asthma: how serious is the problem and what are the issues? Source: Eur Respir Mon 2011; 51: 1-15 Year: 2011